189 Episodo

  1. MET Exon 14 Mutation–Positive NSCLC: FAQ Part 2

    Publicado: 28/8/2020

  2. Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies

    Publicado: 27/8/2020

  3. Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: CLL

    Publicado: 26/8/2020

  4. Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond

    Publicado: 14/8/2020

  5. Tumor Agnostic TRK Inhibitor Therapy and NTRK Fusion Testing: Experts Answer Clinician Questions

    Publicado: 14/8/2020

  6. Improving Outcomes for Patients With CML With TKIs: FAQ Podcast

    Publicado: 13/8/2020

  7. Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies

    Publicado: 10/8/2020

  8. Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types: Answering Clinician Questions

    Publicado: 10/8/2020

  9. Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors

    Publicado: 10/8/2020

10 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site